Skystone Advisors LLC
CIK 0001332634 Name as filed on the most recent filing
Filed as Skystone Advisors LLC (52)
118 transaction lines · from 52 filings · filed 2006-01-30 to 2009-03-26 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
0 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2006-12-07 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 7,485 acquired | 4.80 | 35,897.31 | Form 4, filing 0000929638-06-000518 | |
| 2006-12-04 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 4,900 acquired | 4.82 | 23,610.16 | Form 4, filing 0000929638-06-000506 | |
| 2006-12-01 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 4,579 acquired | 4.60 | 21,061.11 | Form 4, filing 0000929638-06-000504 | |
| 2006-12-01 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 7,035 acquired | 4.64 | 32,634.66 | Form 4, filing 0000929638-06-000504 | |
| 2006-12-01 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 7,035 acquired | 4.64 | 32,634.66 | Form 4, filing 0000929638-06-000495 | |
| 2006-12-01 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 4,579 acquired | 4.60 | 21,061.11 | Form 4, filing 0000929638-06-000495 | |
| 2006-11-30 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 31,097 acquired | 4.51 | 140,343.87 | Form 4, filing 0000929638-06-000504 | |
| 2006-11-29 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 4,106 acquired | 4.30 | 17,667.71 | Form 4, filing 0000929638-06-000504 | |
| 2006-11-29 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 4,106 acquired | 4.30 | 17,667.71 | Form 4, filing 0000929638-06-000495 | |
| 2006-10-06 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 23,346 acquired | 4.42 | 103,215.00 | Form 4, filing 0000929638-06-000412 | |
| 2006-10-06 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 10,300 acquired | 4.43 | 45,660.93 | Form 4, filing 0000929638-06-000412 | |
| 2006-09-27 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 200 acquired | 4.26 | 852.00 | Form 4, filing 0000929638-06-000377 | |
| 2006-09-26 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 36,226 acquired | 4.25 | 154,123.52 | Form 4, filing 0000929638-06-000377 | |
| 2006-09-25 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 1,262 acquired | 4.25 | 5,363.50 | Form 4, filing 0000929638-06-000377 | |
| 2006-08-31 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 10,101 acquired | 4.25 | 42,929.25 | Form 4, filing 0001181431-06-051284 | |
| 2006-08-30 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 54,515 acquired | 4.25 | 231,688.75 | Form 4, filing 0000929638-06-000358 | |
| 2006-08-29 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 1,300 acquired | 4.25 | 5,525.00 | Form 4, filing 0000929638-06-000358 | |
| 2006-08-28 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 3,619 acquired | 4.25 | 15,380.75 | Form 4, filing 0000929638-06-000358 | |
| 2006-08-25 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 545 acquired | 4.25 | 2,316.25 | Form 4, filing 0000929638-06-000353 | |
| 2006-08-24 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 3,337 acquired | 4.25 | 14,182.25 | Form 4, filing 0000929638-06-000353 | |
| 2006-08-23 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 100 acquired | 4.25 | 425.00 | Form 4, filing 0000929638-06-000353 | |
| 2006-08-22 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 18,883 acquired | 4.25 | 80,262.19 | Form 4, filing 0000929638-06-000351 | |
| 2006-08-21 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 5,640 acquired | 4.24 | 23,912.47 | Form 4, filing 0000929638-06-000351 | |
| 2006-08-18 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 902 acquired | 4.11 | 3,704.24 | Form 4, filing 0000929638-06-000351 | |
| 2006-08-08 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 3,830 acquired | 4.25 | 16,277.50 | Form 4, filing 0000929638-06-000312 | |
| 2006-08-07 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 425,962 acquired | 4.25 | 1,809,912.54 | Form 4, filing 0000929638-06-000312 | |
| 2006-07-31 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 99,870 acquired | 4.25 | 424,447.50 | Form 4, filing 0000929638-06-000302 | |
| 2006-07-28 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 5,325 acquired | 4.25 | 22,631.25 | Form 4, filing 0000929638-06-000302 | |
| 2006-07-25 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 300 acquired | 4.25 | 1,275.00 | Form 4, filing 0000929638-06-000299 | |
| 2006-07-24 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 8,808 acquired | 4.25 | 37,434.00 | Form 4, filing 0000929638-06-000299 | |
| 2006-07-21 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 2,935 acquired | 4.25 | 12,471.70 | Form 4, filing 0000929638-06-000299 | |
| 2006-07-19 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 1,852 acquired | 4.25 | 7,871.00 | Form 4, filing 0000929638-06-000296 | |
| 2006-07-18 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 28,429 acquired | 4.25 | 120,820.41 | Form 4, filing 0000929638-06-000296 | |
| 2006-07-17 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 7,131 acquired | 4.25 | 30,306.75 | Form 4, filing 0000929638-06-000296 | |
| 2006-07-14 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 6,150 acquired | 4.25 | 26,128.28 | Form 4, filing 0000929638-06-000285 | |
| 2006-07-13 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 85,224 acquired | 4.25 | 362,184.96 | Form 4, filing 0000929638-06-000285 | |
| 2006-07-12 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 4,213 acquired | 4.25 | 17,905.25 | Form 4, filing 0000929638-06-000285 | |
| 2006-07-11 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 100 acquired | 4.25 | 425.00 | Form 4, filing 0000929638-06-000284 | |
| 2006-07-11 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 100 acquired | 4.25 | 425.00 | Form 4, filing 0000929638-06-000279 | |
| 2006-07-10 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 8,203 acquired | 4.25 | 34,866.85 | Form 4, filing 0000929638-06-000279 | |
| 2006-07-07 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 318 acquired | 4.25 | 1,351.50 | Form 4, filing 0000929638-06-000279 | |
| 2006-07-05 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 7,511 acquired | 4.26 | 31,980.34 | Form 4, filing 0001332634-06-000005 | |
| 2006-07-03 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 206,265 acquired | 4.25 | 876,626.25 | Form 4, filing 0001332634-06-000005 | |
| 2006-06-30 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 20,085 acquired | 4.45 | 89,378.25 | Form 4, filing 0001332634-06-000008 | |
| 2006-06-30 |
Collegiate Pacific Inc BOO |
P, Open-market purchase | 26,600 acquired | 10.49 | 279,103.16 | Form 4, filing 0001332634-06-000007 | |
| 2006-06-30 |
Collegiate Pacific Inc BOO |
P, Open-market purchase | 18,100 acquired | 10.49 | 189,916.06 | Form 4, filing 0001332634-06-000006 | |
| 2006-06-30 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 20,085 acquired | 4.23 | 84,993.69 | Form 4, filing 0001332634-06-000005 | |
| 2006-06-28 |
Collegiate Pacific Inc BOO |
P, Open-market purchase | 18,100 acquired | 10.25 | 185,514.14 | Form 4, filing 0000929638-06-000275 | |
| 2006-06-28 |
Collegiate Pacific Inc BOO |
P, Open-market purchase | 6,200 acquired | 10.36 | 64,215.88 | Form 4, filing 0000929638-06-000275 | |
| 2006-06-27 |
Harvard Bioscience Inc HBIO |
P, Open-market purchase | 204,371 acquired | 4.23 | 864,836.76 | Form 4, filing 0000929638-06-000274 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- P, Open-market purchase
- Open-market purchase
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.
How to cite this page
ebomi catalog. Skystone Advisors LLC, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001332634
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6